Tuesday, March 20, 2018
Company News: Page (1) of 1 - 09/13/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Genomic Health and Biocartis Announce Agreement to Develop an Idylla™ IVD Oncotype DX® Breast Cancer Test to Broaden Global Patient Access
Strategic Collaboration Aimed at Exclusive Test Development and Commercialization of Proprietary Genomic Health Tests on the Idylla™ Platform
(September 13, 2017)
[ServletException in:/common/layout/us_view_template.jsp] null'